J C Penney Company Inc. (NYSE:JCP) is replacing its cozy winter wear with arrangement of spring fashion, sandals and accessories with spring just around the corner. On Wednesday shares of J C Penney Company Inc (NYSE:JCP) closed at $7.88. Company’s sales growth for last 5 years was -8.50%.
Lexicon Pharma (NASDAQ: LXRX) reported Q4 EPS of $0.00, $0.03 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $21.4 million versus the consensus estimate of $11.97 million. Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) in last trading activity advanced 7.14% to close at $1.05. Company weekly performance is 11.70% while its quarterly performance stands at 7.14%. Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) is -45.03% away from its 52 week high.
Altisource Residential Corporation (NYSE:RESI) announced on 02 March 2015, financial and operating results for the fourth quarter and full year of 2014. Net income for the fourth quarter of 2014 totaled $41.5 million, or $0.72 per diluted share, compared to net income of $21.6 million, or $0.50 per diluted share, for the fourth quarter of 2013. Altisource Residential Corporation (NYSE:RESI) has 4.11% insider ownership while its institutional ownership stands at 96.10%. In last trading activity company’s stock closed at $20.75.
Amicus Therapeutics, Inc. (NASDAQ:FOLD) released financial results for the full-year ended December 31, 2014. Cash, cash equivalents, and marketable securities totaled $169.1 million at December 31, 2014 compared to $82.0 million at December 31, 2013. Total operating expenses increased to $69.9 million compared to $64.5 million for the full-year 2013 primarily due to increases in preclinical and clinical development costs on the Fabry monotherapy and Pompe programs. Amicus Therapeutics, Inc. (NASDAQ:FOLD) has 1.80% insider ownership while its institutional ownership stands at 88.20%. In last trading activity company’s stock closed at $8.41.
Zacks upgraded shares of CEL-SCI Corp. (NYSE:CVM) from an underperform rating to a neutral rating in a report issued on Wednesday. On last trading day CEL-SCI Corporation (NYSEMKT:CVM) advanced 4.39% to close at $1.19. Its volatility for the week is 10.98% while volatility for the month is 10.36%. CVM’s sales growth for past 5 years was 24.60% and its EPS growth for past 5 years was 31.10%. CEL-SCI Corporation (NYSEMKT:CVM) monthly performance is 77.61%.